Investors eyeing a purchase of Alnylam Pharmaceuticals Inc (NASD: ALNY) stock, but tentative about paying the going market price of $30.07/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $25 strike, which has a bid at the time of this writing of $1.50. Collecting that bid as the premium represents a 6% return against the $25 commitment, or a 22.8% annualized rate of retu...
Investors eyeing a purchase of Alnylam Pharmaceuticals Inc (NASD: ALNY) stock, but tentative about paying the going market price of $30.07/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $25 strike, which has a bid at the time of this writing of $1.50. Collecting that bid as the premium represents a 6% return against the $25 commitment, or a 22.8% annualized rate of retu...
Share this Article
Recommended